|
2012 is an exciting year for social media: the year social media goes viral.
The pharmaceutical industry have been waiting for guidance from the FDA and now they have finally shed some light with their 'Off-Label Use' with some mention regarding social media. Although this is not directly aimed at social media, the fact that the FDA discusses social media demonstrates the importance.
With this industry moving at a rapid pace, and with more patients and healthcare professionals becoming more tech-savvy, the pharmaceuticals industry need to embrace social media.
Building on the tremendous success of SMi's first three Social Media in Pharamceuticals conference, we are proud to present our fourth event in the series; focused on keeping our audience up-to-date with developments in the ever-changing social media sphere.
|
|
Why should you attend this event?
Key areas covered:
Hear about all the latest regulatory guidances and
Engaging patients and doctors through effective social media channels
Gaining 'buy in' from management and customers to drive social media in the workplace
Improving brand and image reputation
Overcoming cultural barriers and dealing with change management
Establishing the return on investment for your social media activities
First-response: the use of social media in responding first-hand in a crisis
How you will benefit:
Understand how to engage and educate your patietns and healthcare professionals through social media
Learn how to gain 'buy in' and deal with change management effectively
Evaluate the latest trends and developments in the industry
Discover what the future holds in this rapidly evolving market and the impact of social media
Network with all the key professionals in social media in the utilities sector
Hear keynote addresses from:
Greg Kueterman, Director, Corporate Communications, Eli Lilly and Company
Gillian Tachibana, Director, eMedia & Social Media, Merck Serono
Craig DeLarge, Director, Healthcare Professional Relationship Marketing, Novo Nordisk
Richard Bergstrom, Director General, EFPIA (European Federation of Pharmaceutical Industries and Association)
Serkan Ervokan, Lead Senior IS Consultant for Digital Projects, Boehringer Ingelheim
Andrew Widger, Director, Media Relations EMEA, Pfizer
Our expert speaker line-up also includes:
Doris Casares, Social Media Strategist, Spanish Generic Medicines Association
Tova Turkel, Head of Social Media, British Lung Foundation
Mourad Kalai, Project Manager, Roche
Gary Monk, UK Managing Director, Across Group
James Quekett, Director of Educational Services, Doctors.net.uk
John Robinson, User Generated Contact Lead, NHS Choices
John Pugh, Director of Digital and Online Communications, Boehringer Ingelheim
Who should attend?
VP, Director, Head, Manager, Team Leader of:
- Social Media
- Digital Marketing
- Communications
- Marketing
- eMedia
- eMarketing
- Online marketing
- Online media
- Web Design
- Brand Management
- Product Marketing
- Compliance
- Business Development
Conference Documentation
Fancy speaking at the conference? Do you know of anyone who may be interested in speaking? We are always on the look-out for new speakers for our upcoming conferences. Let us know - contact the Conference Producer.
For sponsorship and exhibiting opportunities,contact our Sponsorship Department
|